{"id":4883,"date":"2024-02-21T19:23:25","date_gmt":"2024-02-21T11:23:25","guid":{"rendered":"https:\/\/regask.com\/?p=4883"},"modified":"2024-11-05T20:53:46","modified_gmt":"2024-11-05T12:53:46","slug":"codigo-de-publicidad-farmaceutica-de-health-canada","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/health-canada-review-pharma-advertising-code\/","title":{"rendered":"Cambios propuestos al Aviso de Publicidad Farmac\u00e9utica\u2026"},"content":{"rendered":"<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">\n<div class=\"ewa-rteLine\">Actualmente, Health Canada est\u00e1 analizando una importante renovaci\u00f3n de las normas de publicidad farmac\u00e9utica propuesta por la Junta Asesora de Publicidad Farmac\u00e9utica (PAAB).<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">El objetivo principal es modernizar el enfoque de la evidencia del mundo real (RWE). El borrador del documento de orientaci\u00f3n sobre RWE, desarrollado mediante una amplia colaboraci\u00f3n con la industria, describe un marco transparente y basado en la evidencia para incluir la RWE en la publicidad dirigida a los profesionales de la salud.<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">Los cambios propuestos apuntan a ampliar los hallazgos permisibles de RWE, con criterios estrictos de calidad y relevancia de la evidencia. La revisi\u00f3n tambi\u00e9n se extiende a los criterios de los ensayos cl\u00ednicos, permitiendo puntos finales subjetivos y relajando los requisitos de coincidencia de formulaciones para ensayos de otras jurisdicciones.<\/div>\n<div><\/div>\n<div class=\"ewa-rteLine\">Para obtener un desglose detallado, explore la comparaci\u00f3n del texto tabulado de las secciones del C\u00f3digo actual y las propuestas.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div>\n\t<div id=\"gap-1290530706\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1290530706 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<div id=\"col-2010359898\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/www.paab.ca\/resources\/draft-code-change-currently-undergoing-health-canada-review\/\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Leer m\u00e1s<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<a href=\"https:\/\/regask.com\/es\/contacto\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Soporte de inteligencia regulatoria a su alcance<\/span>\n\t<\/a>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Health Canada is currently scrutinizing a significant revamp of pharmaceutical advertising standards proposed by the Pharmaceutical Advertising Advisory Board (PAAB). The primary focus is on modernizing the approach to Real-World Evidence (RWE). The draft RWE guidance document, developed through extensive industry collaboration, outlines a transparent and evidence-based framework for including RWE in health professional-targeted advertising&#8230;.<\/p>","protected":false},"author":39,"featured_media":7393,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[513,35],"tags":[335,387],"class_list":["post-4883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-canada-regulations","category-pharma-biotech-latest-insights","tag-advertising-regulations","tag-real-word-evidence-rwe"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Health Canada Review: Overhauling Pharmaceutical Advertising<\/title>\n<meta name=\"description\" content=\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/codigo-de-publicidad-farmaceutica-de-health-canada\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Code undergoing Health Canada Review\" \/>\n<meta property=\"og:description\" content=\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/codigo-de-publicidad-farmaceutica-de-health-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-21T11:23:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-05T12:53:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n\t<meta property=\"og:image:width\" content=\"688\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Proposed changes to the Pharmaceutical Advertising Advi&hellip;\",\"datePublished\":\"2024-02-21T11:23:25+00:00\",\"dateModified\":\"2024-11-05T12:53:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"},\"wordCount\":162,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"keywords\":[\"Advertising Regulations\",\"Real-Word-Evidence (RWE)\"],\"articleSection\":[\"Canada\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\",\"name\":\"Health Canada Review: Overhauling Pharmaceutical Advertising\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"datePublished\":\"2024-02-21T11:23:25+00:00\",\"dateModified\":\"2024-11-05T12:53:46+00:00\",\"description\":\"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/health-canada-review-pharma-advertising-code\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png\",\"width\":1600,\"height\":1200,\"caption\":\"Proposed Changes Pharmaceutical Advertising Advisory Board Paab Code Health Canada Review\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Informe de Salud Canad\u00e1: revisi\u00f3n de la publicidad farmac\u00e9utica","description":"Conozca la aceptaci\u00f3n ampliada de la evidencia del mundo real, los ajustes propuestos a los criterios de los ensayos cl\u00ednicos... Leer m\u00e1s | RegASK","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/codigo-de-publicidad-farmaceutica-de-health-canada\/","og_locale":"es_ES","og_type":"article","og_title":"Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Code undergoing Health Canada Review","og_description":"Learn about expanded acceptance of Real-World Evidence, proposed adjustments to clinical trial criteria... Read more | RegASK","og_url":"https:\/\/regask.com\/es\/codigo-de-publicidad-farmaceutica-de-health-canada\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-02-21T11:23:25+00:00","article_modified_time":"2024-11-05T12:53:46+00:00","og_image":[{"width":688,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_image":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#article","isPartOf":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Proposed changes to the Pharmaceutical Advertising Advi&hellip;","datePublished":"2024-02-21T11:23:25+00:00","dateModified":"2024-11-05T12:53:46+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"},"wordCount":162,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","keywords":["Advertising Regulations","Real-Word-Evidence (RWE)"],"articleSection":["Canada","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/","url":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/","name":"Informe de Salud Canad\u00e1: revisi\u00f3n de la publicidad farmac\u00e9utica","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","datePublished":"2024-02-21T11:23:25+00:00","dateModified":"2024-11-05T12:53:46+00:00","description":"Conozca la aceptaci\u00f3n ampliada de la evidencia del mundo real, los ajustes propuestos a los criterios de los ensayos cl\u00ednicos... Leer m\u00e1s | RegASK","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/health-canada-review-pharma-advertising-code\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/proposed-changes-pharmaceutical-advertising-advisory-board-paab-code-health-canada-review.png","width":1600,"height":1200,"caption":"Proposed Changes Pharmaceutical Advertising Advisory Board Paab Code Health Canada Review"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/4883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=4883"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/4883\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/7393"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=4883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=4883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=4883"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}